The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial AG Marson, AM Al-Kharusi, M Alwaidh, R Appleton, GA Baker, ... The Lancet 369 (9566), 1016-1026, 2007 | 1165 | 2007 |
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial AG Marson, AM Al-Kharusi, M Alwaidh, R Appleton, GA Baker, ... The Lancet 369 (9566), 1000-1015, 2007 | 1111 | 2007 |
Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause A Zaidi, P Clough, P Cooper, B Scheepers, AP Fitzpatrick Journal of the American College of Cardiology 36 (1), 181-184, 2000 | 611 | 2000 |
Ketogenic diets for drug‐resistant epilepsy KJ Martin-McGill, R Bresnahan, RG Levy, PN Cooper Cochrane Database of Systematic Reviews, 2020 | 522 | 2020 |
Ketogenic diet and other dietary treatments for epilepsy K Martin, CF Jackson, RG Levy, PN Cooper Cochrane Database of Systematic Reviews, 2016 | 390 | 2016 |
Ketogenic diet and other dietary treatments for epilepsy RG Levy, PN Cooper, P Giri, J Weston Cochrane database of systematic reviews, 2012 | 294 | 2012 |
A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add‐on therapy to carbamazepine in patients with … AP Aldenkamp, G Baker, OG Mulder, D Chadwick, P Cooper, J Doelman, ... Epilepsia 41 (9), 1167-1178, 2000 | 283 | 2000 |
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation PF Chinnery, DE Crompton, D Birchall, MJ Jackson, A Coulthard, ... Brain 130 (1), 110-119, 2007 | 233 | 2007 |
τ Ubiquitin, and αB-Crystallin Immunohistochemistry Define the Principal Causes of Degenerative Frontotemporal Dementia PN Cooper, M Jackson, G Lennox, J Lowe, DMA Mann Archives of Neurology 52 (10), 1011-1015, 1995 | 160 | 1995 |
The early onset dementias: a study of clinical characteristics and service use J Ferran, KEN Wilson, M Doran, E GHADIALI, F Johnson, P Cooper, ... International Journal of Geriatric Psychiatry 11 (10), 863-869, 1996 | 118 | 1996 |
Sudden unexpected death in epilepsy genetics: Molecular diagnostics and prevention CPN Goldman AM, Behr ER, Semsarian C, Bagnall RD, Sisodiya S Epilepsia 15 (S1), 17-15, 2016 | 112* | 2016 |
Parkinson’s disease: summary of updated NICE guidance C Rogers, Davies, Pink BMJ 358, j1951, 2017 | 111 | 2017 |
How to avoid a misdiagnosis in patients presenting with transient loss of consciousness S Petkar, P Cooper, AP Fitzpatrick Postgraduate medical journal 82 (972), 630-641, 2006 | 94 | 2006 |
Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: a comparison with early and advanced Parkinson’s disease JJ Downes, NM Priestley, M Doran, J Ferran, E Ghadiali, P Cooper Behavioural neurology 11 (3), 173-183, 1999 | 81 | 1999 |
The prevalence of epilepsy in the Zay Society, Ethiopia—an area of high prevalence S Almu, Z Tadesse, P Cooper, R Hackett Seizure 15 (3), 211-213, 2006 | 80 | 2006 |
Prolonged implantable electrocardiographic monitoring indicates a high rate of misdiagnosis of epilepsy—REVISE study S Petkar, T Hamid, P Iddon, A Clifford, N Rice, R Claire, D McKee, ... Europace 14 (11), 1653-1660, 2012 | 78 | 2012 |
Clinical experience with perampanel: focus on psychiatric adverse effects H Coyle, P Clough, P Cooper, R Mohanraj Epilepsy & Behavior 41, 193-196, 2014 | 73 | 2014 |
Diagnosis and management of patients with blackouts AP Fitzpatrick, P Cooper Heart 92 (4), 559-568, 2006 | 71 | 2006 |
Multiple sclerosis: summary of NICE guidance M Perry, S Swain, S Kemmis-Betty, P Cooper BMJ 349, 2014 | 50* | 2014 |
A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy D Speed, C Hoggart, S Petrovski, I Tachmazidou, A Coffey, A Jorgensen, ... Human molecular genetics 23 (1), 247-258, 2014 | 48 | 2014 |